The Chemours Company (NYSE:CC) shares have continued their recent momentum with a 33% gain in the last month alone. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 18% over that time.
Even after such a large jump in price, it would still be understandable if you think Chemours is a stock with good investment prospects with a price-to-sales ratios (or “P/S”) of 0.4x, considering almost half the companies in the United States’ Chemicals industry have P/S ratios above 1.2x. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the reduced P/S.
Check out our latest analysis for Chemours
How Chemours Has Been Performing
Recent revenue growth for…
